MongoDB ($MDB): The CEO Left. The Growth Targets Went Up.

MongoDB’s CEO left. The next day, management raised its long-term growth targets.

For investors watching the shares trade roughly 18% below their September 25 close, that is an interesting combination. The leadership uncertainty increased. So did the company’s ambitions.^{1 2 3}

Our read after reviewing the September 29 Investor Day materials: the business gave us more reasons to pay attention. Around $337, the valuation still gives us reasons to be patient.

MongoDB sells database software that applications use to store and retrieve information. Customers can use its managed cloud service, Atlas, or run the software themselves. As AI applications become more capable, they need reliable access to current business data. That gives MongoDB a relevant place to compete.¹

This is why $MDB interests us. A leadership shock has reduced the price investors are willing to pay for a business with an intact near-term forecast. If customers keep spending and execution holds, there could be an opportunity. We still need the entry price to compensate us for the chance that the transition proves disruptive.

CJ Desai departed for a senior role at Meta, and former CEO Dev Ittycheria returned as interim CEO. The permanent leadership question remains open. MongoDB reaffirmed its quarterly and annual guidance on September 28, which helps establish the starting point for evaluating the transition.¹

Investor Day added higher long-term targets:

Company targets. ARR is annualized recurring revenue and differs from recognized revenue. Source: Investor Day, slide 137.³

The higher long-term targets do not represent a fresh near-term earnings upgrade. FY2027 guidance remains $2.99–$3.03 billion in revenue and $6.39–$6.58 in adjusted earnings per share, originally issued September 1. Q2 Atlas revenue grew 29% year over year.⁴

The customer figures give us something firmer than a product roadmap. July-quarter net ARR expansion was 122%, while customers above $100,000 in ARR rose from 2,564 to 2,999. Existing customers were expanding their spending in aggregate. Those figures predate the CEO transition; the next report needs to show that momentum continuing.⁵

The AI disclosures deserve a little care. About 40% of Atlas ARR comes from customers with at least one AI use case. That does not establish how much revenue AI workloads generate. Revenue from AI-native customers grew 165% year over year, but those customers still represent a low-single-digit share of Atlas revenue.³

There is room for that business to become much larger. There is also room for investors to get ahead of the evidence. A fast-growing activity can remain small for quite a while, especially inside an established business.

Management expects initial revenue contributions from Atlas Infinite and Atlas Agent Engine to build in FY2028, with more meaningful impact in FY2029 and beyond. Those fiscal years begin in February 2027 and February 2028, respectively.^{3 5}

The timing matters. We would be paying today for products whose contribution still needs time to develop.

There is another question we find more interesting than the launch headlines: what does better technology do to the customer’s bill?

Atlas Infinite separates compute from storage, allowing customers to scale resources and pay for actual usage instead of provisioning for peak demand. It is in public preview on AWS. Atlas Agent Engine, also in public preview, adds execution, memory and governance for AI agents. Its usage can draw on customers’ existing Atlas commitments.^{6 7}

Our inference is that greater efficiency could reduce spending on an unchanged workload while encouraging customers to bring more applications onto the platform. That could be very good for MongoDB over time. The question is how quickly the additional activity outweighs any savings on existing workloads.

We would watch paid consumption, customer expansion and revenue growth together. A popular feature that does not lead to more spending has a different investment value from one that does.

Which brings us back to the price. At approximately $337 on September 29, our calculation puts enterprise value at about $24.7 billion, or 8.2 times FY2027 guided revenue. The share price is approximately 52 times FY2027 guided adjusted earnings. The enterprise-value calculation uses the latest actual share count and cash balance; potential dilution from equity awards is an additional consideration.^{2 4 5}

Consider a simple example. Revenue grows 20% next year, but investors value the business at seven times that revenue. Holding cash and shares constant gives an illustrative price near $344. The business can grow nicely while the stock goes almost nowhere.

That is the risk in buying an apparently attractive dip without deciding what valuation you are willing to own.

Hayabusa sensitivity calculations, not forecasts or price targets. Cash and shares are held constant. Growth rates and multiples are our illustrative assumptions; no probabilities are assigned.

The downside mechanism is straightforward. Slower customer spending would reduce the revenue outlook. At the same time, uncertainty around execution could make investors pay a lower multiple for those revenues. Both can weigh on the share price together.

The expanded buyback offers some flexibility, but it does not settle the valuation debate. MongoDB added $1 billion of authorization, taking cumulative authorization to $2 billion. About $1.354 billion remained available. That is discretionary purchasing capacity, not completed buying.⁸

First-half stock compensation was $286.8 million against $335.2 million of free cash flow. Compensation paid in shares has an economic cost, even when it does not appear as a current cash expense. We would judge repurchases by their effect on dilution and value per share.^{5 4}

Likewise, FY2027 guidance includes positive GAAP earnings per share while still projecting a GAAP operating loss of $8–$28 million. Operating profit, adjusted profit and bottom-line earnings tell different parts of the story.⁴

For new money, we would wait around $337. A stronger case would require evidence that Atlas consumption and customer expansion remain healthy through the transition, with margins holding up. Clear acceleration would give us more reason to accept a premium valuation.

A lower entry price could also change the balance. Our chosen hurdle of 6.5–7 times FY2027 revenue at the guidance midpoint translates to approximately $273–$291, using unchanged cash and shares. We selected that range to allow for a less generous valuation while leadership and product monetization remain unsettled. It is a point to reassess the business, rather than an automatic purchase instruction.

If weaker consumption or reduced guidance caused the price to fall, the range would need to be recalculated. The same shares at a lower price can come with a weaker business outlook.

At the next earnings report, we will look for Atlas growth near its recent high-20s pace, continued customer expansion, sales-leadership stability and improving economics per share. A guide cut, sustained spending weakness or significant sales disruption would challenge the thesis. The company had not confirmed the next earnings date in the materials reviewed.⁹

MongoDB has given us a business worth following closely. The opportunity will become more compelling if the customer’s spending catches up with the product ambition—and the purchase price leaves enough room for the inevitable surprises.

Valuation and research notes. Figures are as of September 29, 2026, unless otherwise stated. Price is rounded to $337. Enterprise value = $337 × 80.556341 million actual shares (August 28) − $2,411.254 million cash and short-term investments (July 31). No material financial debt is added; lease liabilities are excluded. Revenue and adjusted EPS multiples use FY2027 guidance midpoints of $3.010 billion and $6.485. Actual shares differ from the diluted EPS denominator.

Scenario share value = [FY2027 revenue midpoint × (1 + assumed FY2028 growth) × selected EV/revenue multiple + cash] ÷ actual shares. The entry hurdle uses FY2027 revenue without the growth assumption. These calculations exclude future cash generation, buybacks and dilution. They illustrate sensitivity, not estimated intrinsic value or expected investment returns.

This review uses company filings, releases and the official Investor Day presentation. A complete Investor Day Q&A transcript was unavailable; no live answers are attributed to management.

Sources

1. MongoDB CEO transition release, September 28, 2026. Leadership changes, business description and guidance reaffirmation.
2. ChartExchange: MongoDB price history, September 25–29, 2026. September 29 display: $337.38 near the close; rounded to $337 throughout.
3. Official Investor Day presentation, September 29, 2026, slides 114, 131–133 and 137. SEC presentation exhibit.
4. Q2 FY2027 earnings release, September 1, 2026. Revenue, Atlas growth, outlook, free cash flow and GAAP/non-GAAP distinctions.
5. Q2 FY2027 Form 10-Q, quarter ended July 31, 2026. Share count, cash, stock compensation, customer expansion and fiscal calendar.
6. MongoDB 9.0 and Atlas Infinite announcement, September 29, 2026. Product design and public-preview availability.
7. Atlas Agent Engine announcement, September 29, 2026. Product scope, preview and pricing structure.
8. September 29 Form 8-K, Item 8.01. Buyback authorization and remaining capacity.
9. MongoDB investor-relations events page, reviewed September 29, 2026.